Healthcare Services

Allergy Immunotherapy Market Global Report 2026 Market Revenue Growth Expected to Reach $5.64 Billion by 2030 with 12.2% CAGR

March 27, 2026March 27, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Is The Expected Market Size Of The Allergy Immunotherapy Market From 2026 To 2030?

The allergy immunotherapy market has experienced substantial expansion in recent years. Projections indicate its value will escalate from $3.16 billion in 2025 to $3.55 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 12.3%. Historically, this growth was primarily driven by several factors, including insufficient understanding of allergy immunotherapy, an increase in the occurrence of seasonal allergic rhinitis, reliance on hospital-centric treatment pathways, the use of conventional treatment approaches, and the granting of regulatory approvals for immunotherapy products.

The allergy immunotherapy market is projected to experience substantial growth in the upcoming years. It is anticipated to reach $5.64 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 12.2%. This expansion during the forecast period can be attributed to several factors, including the proliferation of personalized immunotherapy solutions, the increased use of online pharmacy platforms, the broadening of pediatric allergy treatments, escalating investment in immunotherapy research, and the creation of combination immunotherapy products. Furthermore, key trends shaping the forecast period encompass the greater embrace of subcutaneous and sublingual immunotherapy, the increasing incidence of allergic rhinitis and asthma, the broadening scope of treatments for food and venom allergies, a heightened emphasis on individualized allergy treatment plans, and improved awareness leading to earlier diagnosis of allergic conditions.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9416&type=smp

What Drivers Are Influencing The Allergy Immunotherapy Market?

The increasing occurrence of allergic disorders is anticipated to significantly boost the allergy immunotherapy market. Allergic disorders involve exaggerated immune responses to specific antigens, distinct from autoimmune diseases where the immune system inappropriately targets the body’s own components. Allergy immunotherapy offers treatment for atopic individuals experiencing conditions such as IgE-mediated allergic rhinitis and allergic asthma, triggered by inhaled allergens including pollens and house dust mites (HDMs). For instance, in August 2023, the Medicines and Healthcare Products Regulatory Agency (MHRA), a UK-based executive agency, reported that English hospitals recorded over 25,000 admissions for allergies and anaphylaxis in 2022-23, which was more than twice the number seen in the last twenty years. Furthermore, in May 2024, the Food Standards Agency, a UK-based government department, released its Patterns and Prevalence of Adult Food Allergy (PAFA) report, indicating that around 6% of adults in the UK, approximately 2.4 million individuals, are affected by food allergies. This rising prevalence of allergic disorders is thus driving the growth of the allergy immunotherapy market.

Which Segments Are Included In The Analysis Of The Allergy Immunotherapy Market?

The allergy immunotherapy market covered in this report is segmented –

1) By Allergy Type: Allergic Rhinitis, Allergic Asthma, Food Allergy, Venom Allergy, Allergic Conjunctivitis, Environmental Allergies

2) By Treatment: Subcutaneous Immunotherapy (SCIT), Sublingual Immunotherapy, Specific Immunotherapy (SIT)

3) By Channel: Hospital Pharmacy, Retail Pharmacy

Subsegments:

1) By Allergic Rhinitis: Seasonal Allergic Rhinitis, Perennial Allergic Rhinitis

2) By Allergic Asthma: House Dust Mite–Induced Allergic Asthma, Pollen-Induced Allergic Asthma, Animal Dander–Induced Allergic Asthma

3) By Food Allergy: Peanut Allergy, Tree Nut Allergy, Milk Allergy, Egg Allergy, Other Food Allergies

4) By Venom Allergy: Bee Venom Allergy, Wasp Venom Allergy, Hornet Venom Allergy, Other Insect Venom Allergies

5) By Allergic Conjunctivitis: Seasonal Allergic Conjunctivitis, Perennial Allergic Conjunctivitis

6) By Environmental Allergies: House Dust Mite Allergy, Pollen Allergy, Mold Allergy, Animal Dander Allergy

Which Trends Are Impacting The Growth Of The Allergy Immunotherapy Market?

Major companies within the allergy immunotherapy market are advancing technological products, such as artificial intelligence (AI)-powered allergy component testing, to uphold their market presence. This AI-powered allergy component testing is an innovative diagnostic platform based on component resolved diagnostics (CRD) for identifying various types of allergies. For instance, in May 2023, Metropolis Healthcare Limited, an Indian Medical laboratory company, launched its artificial intelligence (AI)-powered allergy component testing. This fourth-generation allergy testing technology leverages Artificial Intelligence (AI) to aid clinicians in their decision-making, providing significant insights for selecting and optimizing treatment approaches for allergic diseases. It can also predict the effectiveness of immunotherapy for allergy vaccinations.

Which Key Industry Participants Are Active In The Allergy Immunotherapy Market?

Major companies operating in the allergy immunotherapy market are LETI Pharma, Stallergenes Greer International AG, Allergy Therapeutics plc, ALK-Abelló A/S, HAL Allergy B.V., DBV Technologies, Circassia Pharmaceuticals Inc., Jubilant HollisterStier LLC, Allergopharma GmbH & Co. KG, Biomay AG, Anergis SA, HollisterStier Allergy, Desentum Oy, WOLW Pharma Limited, AllerGenics Inc., Greer Laboratories Inc., Aimmune Therapeutics Inc., Reliant Laboratories Inc., Mylan N.V., Adamis Pharmaceuticals Corporation, Endo Pharmaceuticals Inc., Sun Pharmaceutical Industries Ltd., Cipla Ltd.

Read the full allergy immunotherapy market report here:

https://www.thebusinessresearchcompany.com/report/allergy-immunotherapy-global-market-report

Which Regions Are Expected To Experience Rapid Expansion In The Allergy Immunotherapy Market?

Europe was the largest region in the allergy immunotherapy market in 2025. Asia-Pacific is expected to be the fastest-growing region in the allergy immunotherapy market report during the forecast period. The regions covered in the allergy immunotherapy market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Allergy Immunotherapy Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=9416&type=smp

Browse Through More Reports Similar to the Global Allergy Immunotherapy Market 2026, By The Business Research Company

allergy treatment global market report

https://www.thebusinessresearchcompany.com/report/allergy-treatment-global-market-report

allergy diagnostics global market report

https://www.thebusinessresearchcompany.com/report/allergy-diagnostics-global-market-report

cellulars immunotherapy global market report

https://www.thebusinessresearchcompany.com/report/cellulars-immunotherapy-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795